Pharmacokinetics of a novel extended half-life glyco PEGylated factor IX, nonacog beta pegol (N9- GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.
Saved in:
| Title: | Pharmacokinetics of a novel extended half-life glyco PEGylated factor IX, nonacog beta pegol (N9- GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials. |
|---|---|
| Authors: | Tiede, A.1, Abdul-Karim, F.2, Carcao, M.3, Persson, P.4, Clausen, W. H. O.4, Kearney, S.5, Matsushita, T.6, Negrier, C.7, Oldenburg, J.8, Santagostino, E.9, Young, G.10 |
| Source: | Haemophilia. Jul2017, Vol. 23 Issue 4, p547-555. 9p. 3 Charts, 4 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
